NovoCure Limited - Ordinary Shares (NVCR) Covered Calls

NovoCure Limited - Ordinary Shares covered calls NovoCure Ltd is a commercial stage oncology company. It is engaged in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.

You can sell covered calls on NovoCure Limited - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NVCR (prices last updated Tue 4:16 PM ET):

NovoCure Limited - Ordinary Shares (NVCR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.44 +0.04 19.05 20.12 868K - 2.1
Covered Calls For NovoCure Limited - Ordinary Shares (NVCR)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 21 20 0.20 19.92 0.4% 36.5%
Jul 19 20 1.35 18.77 6.6% 75.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Novocure Ltd. operates as a commercial-stage oncology company. It offers devices for continuous home use by patients. The firm develops novottf-100A, a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in Haifa, Israel.